The UK announces its first Vaccines Manufacturing Innovation Centre
The UK will establish its first dedicated Vaccine Manufacturing Innovation Centre, with a view to remaining at the forefront of worldwide efforts to tackle life-threatening diseases, including preparing for the rapid manufacture of vaccines in the event of a pandemic.
The Centre will be built at the Oxford Science Park and is expected to open its doors in 2022. The London School of Hygiene & Tropical Medicine is proud to be one of the three academic partners, along with the University of Oxford and Imperial College, and the initiative will be supported by Janssen, Merck and GE Healthcare.
Professor Beate Kampmann, Director of the Vaccine Centre at the London School of Hygiene & Tropical Medicine, commented: “This timely collaborative initiative between the UK government, leading academic institutions and industry will allow us to bridge a critical bottleneck in our fight against emerging infections where life saving vaccines- produced in sufficient stocks to international standards- are needed very quickly!”.
To learn more, please click here.